Mendoza Jose-Andres, Jacob Yves, Cassonnet Patricia, Favre Michel
Unité postulante de Génétique, Papillomavirus et Cancer Humain, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex, France.
J Virol. 2006 Dec;80(24):12420-4. doi: 10.1128/JVI.02576-05. Epub 2006 Oct 4.
Mechanisms of cellular transformation associated with human papillomavirus type 5 (HPV5), which is responsible for skin carcinomas in epidermodysplasia verruciformis (EV) patients, are poorly understood. Using a yeast two-hybrid screening and molecular and cellular biology experiments, we found that HPV5 oncoprotein E6 interacts with SMAD3, a key component in the transforming growth factor beta1 (TGF-beta1) signaling pathway. HPV5 E6 inhibits SMAD3 transactivation by destabilizing the SMAD3/SMAD4 complex and inducing the degradation of both proteins. Interestingly, the E6 protein of nononcogenic EV HPV9 failed to interact with SMAD3, suggesting that downregulation of the TGF-beta1 signaling pathway could be a determinant in HPV5 skin carcinogenesis.
与5型人乳头瘤病毒(HPV5)相关的细胞转化机制目前仍知之甚少,该病毒可导致疣状表皮发育不良(EV)患者患皮肤癌。通过酵母双杂交筛选以及分子和细胞生物学实验,我们发现HPV5癌蛋白E6与SMAD3相互作用,SMAD3是转化生长因子β1(TGF-β1)信号通路的关键组成部分。HPV5 E6通过破坏SMAD3/SMAD4复合物的稳定性并诱导这两种蛋白质的降解来抑制SMAD3反式激活。有趣的是,非致癌性EV HPV9的E6蛋白未能与SMAD3相互作用,这表明TGF-β1信号通路的下调可能是HPV5皮肤癌发生的一个决定因素。